1. Home
  2. OP vs CSCI Comparison

OP vs CSCI Comparison

Compare OP & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OP
  • CSCI
  • Stock Information
  • Founded
  • OP 2021
  • CSCI 1990
  • Country
  • OP Greece
  • CSCI Canada
  • Employees
  • OP N/A
  • CSCI N/A
  • Industry
  • OP
  • CSCI
  • Sector
  • OP
  • CSCI
  • Exchange
  • OP Nasdaq
  • CSCI NYSE
  • Market Cap
  • OP 10.5M
  • CSCI 11.1M
  • IPO Year
  • OP N/A
  • CSCI 1996
  • Fundamental
  • Price
  • OP $1.12
  • CSCI $2.66
  • Analyst Decision
  • OP
  • CSCI
  • Analyst Count
  • OP 0
  • CSCI 0
  • Target Price
  • OP N/A
  • CSCI N/A
  • AVG Volume (30 Days)
  • OP 19.7K
  • CSCI 4.7K
  • Earning Date
  • OP 12-24-2024
  • CSCI 11-12-2024
  • Dividend Yield
  • OP N/A
  • CSCI N/A
  • EPS Growth
  • OP N/A
  • CSCI N/A
  • EPS
  • OP N/A
  • CSCI N/A
  • Revenue
  • OP $22,098,000.00
  • CSCI $4,834,000.00
  • Revenue This Year
  • OP N/A
  • CSCI N/A
  • Revenue Next Year
  • OP N/A
  • CSCI N/A
  • P/E Ratio
  • OP N/A
  • CSCI N/A
  • Revenue Growth
  • OP 9.82
  • CSCI N/A
  • 52 Week Low
  • OP $1.04
  • CSCI $2.62
  • 52 Week High
  • OP $3.15
  • CSCI $11.10
  • Technical
  • Relative Strength Index (RSI)
  • OP 23.21
  • CSCI N/A
  • Support Level
  • OP $1.40
  • CSCI N/A
  • Resistance Level
  • OP $1.50
  • CSCI N/A
  • Average True Range (ATR)
  • OP 0.04
  • CSCI 0.00
  • MACD
  • OP -0.01
  • CSCI 0.00
  • Stochastic Oscillator
  • OP 0.00
  • CSCI 0.00

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

About CSCI COSCIENS BIOPHARMA INC

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.

Share on Social Networks: